AtriCure Inc
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and li… Read more
Market Cap & Net Worth: AtriCure Inc (ATRC)
AtriCure Inc (NASDAQ:ATRC) has a market capitalization of $1.47 Billion ($1.47 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6019 globally and #3453 in its home market, demonstrating a 0.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AtriCure Inc's stock price $29.58 by its total outstanding shares 49716988 (49.72 Million).
AtriCure Inc Market Cap History: 2015 to 2026
AtriCure Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.12 Billion to $1.47 Billion (4.23% CAGR).
Index Memberships
AtriCure Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.06% | #173 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #710 of 3165 |
Weight: AtriCure Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AtriCure Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AtriCure Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.27x
AtriCure Inc's market cap is 3.27 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.12 Billion | $129.75 Million | -$27.21 Million | 8.60x | N/A |
| 2016 | $972.96 Million | $155.11 Million | -$33.34 Million | 6.27x | N/A |
| 2017 | $906.84 Million | $174.72 Million | -$26.89 Million | 5.19x | N/A |
| 2018 | $1.52 Billion | $201.63 Million | -$21.14 Million | 7.55x | N/A |
| 2019 | $1.62 Billion | $230.81 Million | -$35.19 Million | 7.00x | N/A |
| 2020 | $2.77 Billion | $206.53 Million | -$48.16 Million | 13.40x | N/A |
| 2021 | $3.46 Billion | $274.33 Million | $50.20 Million | 12.60x | 68.86x |
| 2022 | $2.21 Billion | $330.38 Million | -$46.47 Million | 6.68x | N/A |
| 2023 | $1.77 Billion | $399.25 Million | -$30.44 Million | 4.44x | N/A |
| 2024 | $1.52 Billion | $465.31 Million | -$44.70 Million | 3.27x | N/A |
Competitor Companies of ATRC by Market Capitalization
Companies near AtriCure Inc in the global market cap rankings as of March 18, 2026.
Key companies related to AtriCure Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
AtriCure Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, AtriCure Inc's market cap moved from $1.12 Billion to $ 1.47 Billion, with a yearly change of 4.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.47 Billion | -25.23% |
| 2025 | $1.97 Billion | +29.45% |
| 2024 | $1.52 Billion | -14.37% |
| 2023 | $1.77 Billion | -19.58% |
| 2022 | $2.21 Billion | -36.17% |
| 2021 | $3.46 Billion | +24.90% |
| 2020 | $2.77 Billion | +71.24% |
| 2019 | $1.62 Billion | +6.24% |
| 2018 | $1.52 Billion | +67.76% |
| 2017 | $906.84 Million | -6.80% |
| 2016 | $972.96 Million | -12.79% |
| 2015 | $1.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of AtriCure Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.47 Billion USD |
| MoneyControl | $1.47 Billion USD |
| MarketWatch | $1.47 Billion USD |
| marketcap.company | $1.47 Billion USD |
| Reuters | $1.47 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.